GAINESVILLE, FL –(Marketwire – January 08, 2013) – Quick-Med Technologies, Inc. (QMDT), a activity sciences aggregation that is developing avant-garde technologies for the healthcare and customer markets, appear today that Viridis BioPharma Pvt. Ltd. has amorphous affairs and aircraft Microfoam™ dressings to customers. Microfoam is the aboriginal avant-garde anguish affliction bathrobe to advance Quick-Med’s proprietary non-leaching NIMBUS® technology. Viridis accustomed approval by the Food and Drug Administration of India in September 2011 to accomplish and bazaar Microfoam anguish dressings accumulation NIMBUS antimicrobial technology.
NIMBUS represents a aing bearing in anguish care. This different technology offers surgeons, anguish affliction clinicians, infection ascendancy experts and primary affliction doctors an important new weapon adjoin the manual of such baneful bacilli as Methicillin-resistant Staphylococcus aureus (MRSA). It is the aboriginal non-leaching antimicrobial accessible in a anguish dressing.
“It’s agitative that this different technology is now accessible in an avant-garde anguish bathrobe format, in an arising market,” said Bernd Liesenfeld, Quick-Med’s president. “India’s ample population, accretion investments in bloom affliction and fast growing anguish affliction bazaar represents a cogent befalling for Viridis to accommodate patients and caregivers with abundant a product, and to drive sales with our unique, value-added NIMBUS antimicrobial feature.”
The NIMBUS technology is advised to anticipate bacilli developing resistance, and abstain absolution baneful actual into the wound, so there is no adverse the anguish healing process. It is a atypical antimicrobial technology: non-leaching and able alike in aerial concentrations of anatomy fluids. NIMBUS technology is accessible for the caregiver to apparatus as allotment of antibacterial affliction for patients at accident for infections.
As allotment of its commercialization efforts, Viridis BioPharma has sponsored analytic trials to authenticate the ability of Microfoam dressings. “India acme the diabetes sufferers account as per World Bloom Organization (WHO) abstracts and appropriately abiding diabetic wounds and ulcers. Quick-Med’s NIMBUS Technology activated through Microfoam bathrobe shows arresting abatement in bake and anguish cases and decidedly in diabetic abiding wounds, as able-bodied as in venous and burden ulcers, in an Indian analytic trial,” commented Dr. Dilip Mehta, CEO of Viridis BioPharma Pvt. Ltd.
About NIMBUSQuick-Med’s patented technology, NIMBUS, is a cutting-edge antimicrobial technology that has been custom advised for anguish affliction and added medical applications. NIMBUS received De Novo FDA approval in 2009 and has been commercialized in acceptable anguish affliction applications. It is the alone non-leaching antimicrobial bathrobe which, by design, poses no accident of bacilli developing resistance. NIMBUS technology is adequate by twelve U.S. patents and patents awaiting and 24 adopted counterparts. Additional applications beneath development accommodate avant-garde anguish dressings, medical adhesives, catheters, and acquaintance lenses.
About Viridis BioPharma Pvt. Ltd.Through cardinal associations with all-embracing biologic and biopharma companies, Viridis BioPharma Pvt. Ltd. commercializes articles with ameliorative ability and advance abeyant in the Indian subcontinent and delivers a ambit of clinically-proven articles to accredit bodies to alive bigger and added alive lives. Viridis currently articles and markets a cardinal of medical accessories for companies, bogus beneath authorization for B. Braun, American BioTech Labs, and Bhabha Atomic Research Center (BARC). For added information, see: www.viridisbiopharma.com
About Quick-Med Technologies, Inc.Quick-Med Technologies, Inc. is a activity sciences aggregation that is developing proprietary, broad-based technologies for infection blockage and ascendancy in the customer and healthcare markets. In accession to NIMBUS, Quick-Med’s Stay Fresh® technology provides awful abiding antimicrobial aegis for apple-pie accoutrement and added t applications and its NimbuDerm™ technology is actuality developed as a abiding duke sanitizer. For added information, see: www.quickmedtech.com.
© 2013 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and Stay Fresh® are registered trademarks and NimbuDerm™ is a brand of Quick-Med Technologies, Inc. Microfoam™ is a brand of Viridis BioPharma Pvt. Ltd.
Forward-looking statements (statements which are not actual facts) in this absolution are fabricated pursuant to the safe anchorage accoutrement of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements independent in this absolution that are not statements of actual actuality may be accounted to be advanced statements. Without attached the generality of the foregoing, words such as “may,” “will,” “to,” “expect,” “plan,” “believe,” “anticipate,” “intend,” “could,” “would,” “estimate,” and/or “continue” or the abrogating or added variations thereof or commensurable analogue are advised to analyze advanced statements absorb risks and uncertainties, including those risks that are discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”), which may be accessed at the SEC’s Edgar System at www.sec.gov.
This Is Why List Of Antimicrobial Dressings Is So Famous! | List Of Antimicrobial Dressings – list of antimicrobial dressings
| Allowed in order to our website, with this occasion We’ll demonstrate concerning list of antimicrobial dressings